The Pharma Navigator

Lonza has announced the opening of its new Media Development Lab at its Singapore site to expand its capabilities in cell culture media services and support customers across Asia and beyond. Read here👇 thepharmanavigator.com/news/lonza-lau…

Aptar Pharma has entered into a technical collaboration with Australian biotech, COVIRIX Medical, to assess whether it can adapt its proprietary dry powder inhalation (DPI) platform for the delivery of COVIRIX Medical’s antiviral compound. Read here👇 thepharmanavigator.com/news/partnersh…

In Episode 2 of Charting the Best Course, Russell Miller, Vice President, Global Sales and Marketing, @enzenebio shares how continuous bioprocessing is gaining momentum as a powerful alternative to traditional batch manufacturing. Watch here👇 thepharmanavigator.com/news/tipping-t…

The pharmaceutical excipient landscape is undergoing a period of unprecedented transformation. The recent IPEC Europe Excipients Forum, held on Feb. 5, 2026, served as a critical forum for stakeholders to dissect these shifts. Read here👇 thepharmanavigator.com/news/a-new-era…

ESTEVE CDMO has announced a new 3,000-square-meter production unit at its Celrà facility in Girona, Spain, building on the EUR 100 million investment program the company announced in June 2024. Read here👇 thepharmanavigator.com/news/esteve-cd…

Wilmington PharmaTech will add new reactor suites to its Delaware campus, increasing its API reactor capacity by more than double and enabling the company to meet new demand for high-quality domestic manufacturing. Read here👇 thepharmanavigator.com/news/wilmingto…

Advanced therapy medicinal products (ATMPs) are groundbreaking, innovative treatments for many patients once considered untreatable. Listen to the full conversation from Terrapinn’s Advanced Therapies Congress 2026. Listen here👇 thepharmanavigator.com/news/atmps-at-…

Trenchant BioSystems and Invetech Group have completed a strategic alliance aimed at accelerating development of Trenchant's AutoCell platform, a fully automated manufacturing system for cell and gene therapies. Read here👇 thepharmanavigator.com/news/alliance-…

Sterile pharmaceutical contract manufacturer, LYOCONTRACT, has announced a EUR 50 million production expansion at its facility in Ilsenburg, Germany. Read here👇 thepharmanavigator.com/news/lyocontra…

AbbVie has announced positive topline results from a Phase I clinical trial of its investigational obesity drug, ABBV-295, marking a significant early milestone in its bid to bring a new class of weight-loss drug to market. Read here👇 thepharmanavigator.com/news/abbvie-ta…

To secure the long-term continuity of global supply there needs to be a convergence of operational excellence and advanced chemistry, note Almac’s James Hurst and Prof. Tom Moody. Read here👇 thepharmanavigator.com/news/dcat-week…

In this brief guide to DCAT Week 2026, The Pharma Navigator explores some of the critical dialogues’ attendees can look forward to participating in during their stay in Manhattan. Read here👇 thepharmanavigator.com/news/navigatin…

According to Maja Pedersen from FUJIFILM Biotechnologies, modularity, AI-driven compliance, and harmonized global networks are necessary to resolve complexity challenges in downstream processing. Read here👇 thepharmanavigator.com/news/dcat-week…

As sponsors navigate the complexities of a global supply environment, partnering with CDMOs who can anticipate issues and optimize processes is essential to avoid unnecessary cost hurdles, notes Kent Payne from Wilmington PharmaTech. Read here👇 thepharmanavigator.com/news/dcat-week…

As emerging therapies target increasingly niche genetic pathways, the adoption of AI modeling, organoids, and advanced AAV delivery is becoming essential to ensure successful clinical progression and patient access. Read here👇 thepharmanavigator.com/news/opening-t…

According to Carrie Bracco from Novartis Contract Manufacturing, by leveraging large-scale infrastructure, embedded CMOs can help meet rising demand for localized manufacturing. Watch the interview here👇 thepharmanavigator.com/news/dcat-week…

ESTEVE CDMO has revealed its USD 15.5 million investment plans to enhance production capabilities and associated space at its newly acquired North American facility in Morton Grove, Illinois. Read here👇 thepharmanavigator.com/news/esteve-in…

Global strategic partner, Charles River Laboratories is divesting its CDMO and Cell Solutions businesses and select European discovery services sites in two separate transactions. Read the full article here👇 thepharmanavigator.com/news/charles-r…

Lifecore Biomedical and clinical-stage therapeutics company, Indomo, have entered into a new arrangement that will see Lifecore provide Indomo with support to develop an innovative drug–device combination acne treatment. Read here👇 thepharmanavigator.com/news/lifecore-…

Codis has purchased a GEA Pharma-SD type PSD-4 solvent-capable spray dryer, significantly expanding its UK manufacturing capabilities. Read here👇 thepharmanavigator.com/news/codis-sig…